Scpharmaceuticals Inc (OQ:SCPH)

Business Focus: Pharmaceuticals

Apr 24, 2024 08:00 am ET
scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection
scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare...
Mar 13, 2024 04:01 pm ET
scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Mar 06, 2024 04:01 pm ET
scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that...
Feb 28, 2024 04:01 pm ET
scPharmaceuticals to Participate in Two Upcoming Investor Conferences
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Jan 04, 2024 04:05 pm ET
scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue
scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare...
Nov 08, 2023 04:01 pm ET
scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Nov 01, 2023 04:05 pm ET
scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that...
Oct 31, 2023 08:00 am ET
scPharmaceuticals to Participate in Two Upcoming Investor Conferences
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Oct 05, 2023 08:00 am ET
scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
scPharmaceuticals Inc. (Nasdaq: SCPH) (“scPharmaceuticals” or the “Company”), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare...
Sep 19, 2023 08:00 am ET
scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Sep 05, 2023 08:00 am ET
scPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Aug 10, 2023 04:01 pm ET
scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Aug 03, 2023 08:00 am ET
scPharmaceuticals to Announce Second Quarter 2023 Financial Results on Thursday, August 10, 2023
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that...
Aug 01, 2023 08:00 am ET
scPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Jul 19, 2023 08:00 am ET
scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
scPharmaceuticals Inc. (Nasdaq: SCPH) (“scPharmaceuticals” or the “Company”), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare...
Jun 23, 2023 08:00 am ET
scPharmaceuticals Inc. Announces Addition to Russell 2000® and Russell 3000® Indexes
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
May 31, 2023 11:20 am ET
Thinking about buying stock in Krystal Biotech, Axsome Therapeutics, 89bio, Scpharmaceuticals, or Decibel Therapeutics?
NEW YORK, May 31, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for KRYS, AXSM, ETNB, SCPH, and DBTX.
May 31, 2023 08:00 am ET
scPharmaceuticals to Present at the Jefferies Healthcare Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
May 10, 2023 04:01 pm ET
scPharmaceuticals Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
May 02, 2023 08:00 am ET
scPharmaceuticals to Announce First Quarter 2023 Financial Results on Wednesday, May 10, 2023
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that...
Mar 22, 2023 04:05 pm ET
scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Mar 15, 2023 08:00 am ET
scPharmaceuticals to Announce Fourth Quarter and Full-Year 2022 Financial Results on Wednesday, March 22
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that...
Feb 23, 2023 08:00 am ET
scPharmaceuticals to Participate in the Cowen 43rd Annual Health Care Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Feb 21, 2023 08:00 am ET
scPharmaceuticals Announces Launch and Commercial Availability of FUROSCIX® (furosemide injection)
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced the launch and...
Feb 06, 2023 08:00 am ET
scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
scPharmaceuticals Inc. (Nasdaq: SCPH) (“scPharmaceuticals” or the “Company”), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare...
Jan 31, 2023 08:00 am ET
scPharmaceuticals to Participate in the SVB Securities Global Biopharma Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Jan 30, 2023 08:00 am ET
scPharmaceuticals Provides FUROSCIX® (furosemide injection) Commercial Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that the company is...
Dec 19, 2022 08:00 am ET
scPharmaceuticals Inc. Announces Appointment of Rachael Nokes as Chief Financial Officer
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced the appointment of...
Dec 14, 2022 08:00 am ET
scPharmaceuticals to Participate in the 12th Annual LifeSci Partners Corporate Access Event
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Nov 22, 2022 08:01 am ET
scPharmaceuticals Announces Pricing of $50 Million Public Offering
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Nov 21, 2022 04:01 pm ET
scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Nov 09, 2022 04:05 pm ET
scPharmaceuticals Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Nov 02, 2022 08:00 am ET
scPharmaceuticals to Participate in the Jefferies London Healthcare Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Oct 26, 2022 08:00 am ET
scPharmaceuticals to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 9, 2022
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Oct 10, 2022 09:41 am ET
UPDATE - scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide injection), the First and Only Self-administered, Subcutaneous Loop Diuretic for the At-home Treatment of Congestion in Chron
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Oct 10, 2022 08:05 am ET
scPharmaceuticals Announces $100 Million Debt Financing Agreement with Oaktree
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Oct 10, 2022 08:00 am ET
scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide injection), the First and Only Self-administered, Subcutaneous Loop Diuretic for the At-home Treatment of Congestion in Chronic Heart
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Sep 30, 2022 08:00 am ET
scPharmaceuticals Announces Data Presentations at the Heart Failure Society of America 2022 Annual Scientific Meeting
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Sep 01, 2022 08:00 am ET
scPharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, announced...
Aug 09, 2022 07:00 am ET
scPharmaceuticals Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Jul 13, 2022 08:00 am ET
scPharmaceuticals Inc. to Participate in the Maxim Group LLC Late-Stage Advancements in Heart Failure Therapeutics and Management Panel Discussion
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, announced...
Jul 12, 2022 08:00 am ET
scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Jun 30, 2022 08:00 am ET
scPharmaceuticals Inc. to Host FUROSCIX® (furosemide) 80mg/10mL for Subcutaneous Administration Commercial Day: An Investigational Treatment for Heart Failure Patients
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Jun 07, 2022 08:00 am ET
scPharmaceuticals Inc. Announces Abstracts Accepted for Presentation at the American Association of Heart Failure Nurses 18th Annual Meeting
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
May 24, 2022 08:00 am ET
scPharmaceuticals to Present at the Jefferies Healthcare Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker,...
May 17, 2022 08:00 am ET
scPharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker,...
May 16, 2022 07:10 am ET
scPharmaceuticals Inc. Reports First Quarter 2022 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
May 16, 2022 07:00 am ET
scPharmaceuticals Inc. Announces FDA Acceptance of FUROSCIX® New Drug Application
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Apr 11, 2022 07:00 am ET
scPharmaceuticals Inc. Announces Resubmission of FUROSCIX® New Drug Application
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Mar 22, 2022 07:00 am ET
scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Mar 01, 2022 04:05 pm ET
Lantheus Announces Appointment of Minnie Baylor-Henry as New Board Member
Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), today announced the appointment of Ms. Minnie Baylor-Henry, Esq., a renowned expert in regulatory affairs and compliance in the life sciences industry, to Lantheus’ Board of Directors...
Feb 16, 2022 04:05 pm ET
scPharmaceuticals to Present at the 42nd Annual Cowen Healthcare Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker,...
Feb 03, 2022 08:00 am ET
scPharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker,...
Dec 20, 2021 04:05 pm ET
scPharmaceuticals to Participate in Two Upcoming Investor Conferences
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker,...
Nov 09, 2021 07:00 am ET
scPharmaceuticals Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Nov 02, 2021 08:30 am ET
scPharmaceuticals to Present at the Jefferies London Healthcare Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker,...
Sep 10, 2021 08:00 am ET
scPharmaceuticals Inc. Presents Late-breaking FREEDOM-HF Study Data at the Heart Failure Society of America Annual Scientific Meeting 2021
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Sep 01, 2021 08:00 am ET
scPharmaceuticals to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Aug 11, 2021 07:00 am ET
scPharmaceuticals Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Jul 13, 2021 04:08 pm ET
scPharmaceuticals Inc. Announces Positive Top-Line Results from FREEDOM-HF Study
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Jul 01, 2021 08:00 am ET
scPharmaceuticals Inc. Announces Receipt of Written Minutes from Type C Meeting with the FDA Regarding Development of FUROSCIX®
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
May 19, 2021 08:00 am ET
scPharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
May 12, 2021 08:00 am ET
scPharmaceuticals Inc. Reports First Quarter 2021 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Mar 23, 2021 07:00 am ET
scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare...
Feb 25, 2021 08:00 am ET
scPharmaceuticals to Present in Two Upcoming Investor Conferences
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Feb 23, 2021 08:00 am ET
scPharmaceuticals Inc. Announces Results of Type A End-of-Review Meeting with FDA Regarding FUROSCIX® NDA
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Feb 17, 2021 08:00 am ET
scPharmaceuticals Inc. Appoints Renowned Heart Failure Specialist William T. Abraham, M.D., to its Board of Directors
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Feb 11, 2021 08:00 am ET
scPharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Dec 10, 2020 01:18 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of scPharmaceuticals Inc. - SCPH
NEW YORK, Dec. 10, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of scPharmaceuticals Inc. ("scPharmaceuticals" or the "Company") (NASDAQ: SCPH). uch investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980.
Dec 07, 2020 08:00 am ET
scPharmaceuticals Inc. Receives Complete Response Letter from FDA for FUROSCIX®
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Nov 19, 2020 08:00 am ET
scPharmaceuticals to Present at the 3rd Annual Evercore ISI Virtual HealthCONx Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Nov 16, 2020 07:00 am ET
scPharmaceuticals Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Nov 11, 2020 08:00 am ET
scPharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker,...
Oct 08, 2020 08:00 am ET
scPharmaceuticals Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today provided a business update on FUROSCIX®, its investigational proprietary formulation of furosemide for subcutaneous administration.
Sep 17, 2020 08:00 am ET
scPharmaceuticals Hosting Key Opinion Leader Call on FUROSCIX® (furosemide) for subcutaneous administration
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced it will host a key opinion leader (KOL) call on FUROSCIX® (furosemide) 80mg/10mL for subcutaneous administration, an investigational subcutaneous diuretic therapy for the outpatient treatment of congestion in patients with heart failure, on Tuesday, September 29, 2020 at 11am Eastern Time.
Sep 03, 2020 08:00 am ET
scPharmaceuticals to Participate in Two Upcoming Investor Conferences
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that management will participate in two upcoming investor conferences.
Aug 13, 2020 07:00 am ET
scPharmaceuticals Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced financial results for the second quarter ended June 30, 2020 and provided a business update.
Jul 27, 2020 08:00 am ET
scPharmaceuticals Announces FDA Acceptance of FUROSCIX® New Drug Application Resubmission
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) resubmission for FUROSCIX®. scPharmaceuticals is developing FUROSCIX, a proprietary, subcutaneously delivered furosemide solution, as an outpatient alternative for the treatment of worsening heart failure due to congestion
Jul 10, 2020 08:00 am ET
scPharmaceuticals Appoints Sara Bonstein to Board of Directors
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced the appointment of Sara Bonstein to its Board of Directors. Ms. Bonstein fills the vacancy created from Dorothy Coleman’s resignation from the Board of Directors. Ms. Coleman stepped down from the Board after serving since April 2015.
Jul 01, 2020 08:00 am ET
scPharmaceuticals Announces FUROSCIX® NDA Resubmission
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that it has resubmitted its 505(b)(2) New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of FUROSCIX® (subcutaneous furosemide) for the treatment of congestion in patients with heart failure. The NDA resubmission is intended to address concerns raised in the FDA’s June 2018 Complete Response Let
Jun 18, 2020 08:00 am ET
scPharmaceuticals Announces New Presentation Time for BMO’s Virtual 2020 Prescriptions for Success Healthcare Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced a new presentation time for BMO’s Virtual 2020 Prescriptions for Success Healthcare Conference, which is being held on Tuesday, June 23. John Tucker, chief executive officer, is now scheduled to present at 2:30pm EDT. The original announced presentation time was 11:30am EDT.
May 28, 2020 08:00 am ET
scPharmaceuticals Inc. to Present at Upcoming Investor Conferences
scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, chief executive officer, will present at the following investor conferences in June:
May 20, 2020 11:18 pm ET
scPharmaceuticals Announces Pricing of Public Offering of Common Stock
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced the pricing of an underwritten public offering of 5,780,347 shares of its common stock at a public offering price of $8.65 per share, before deducting underwriting discounts and commissions and other offering expenses, for gross proceeds of approximately $50.0 million. All shares of common stock to be sold in the offering are being offered by sc
May 20, 2020 04:01 pm ET
scPharmaceuticals Inc. Announces Proposed Underwritten Public Offering of Common Stock
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that it has commenced an underwritten public offering of shares of its common stock. All shares of common stock to be sold in the offering will be offered by scPharmaceuticals. In addition, the underwriters will have a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering at the public off
May 12, 2020 07:00 am ET
scPharmaceuticals Inc. Reports First Quarter 2020 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced financial results for the first quarter ended March 31, 2020 and provided a business update.
Mar 24, 2020 07:00 am ET
scPharmaceuticals Inc. Reports Fourth Quarter and Year Ended 2019 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced financial results for the fourth quarter and year ended December 31, 2019 and provided a business update.
Feb 26, 2020 08:00 am ET
scPharmaceuticals Inc. to Present at the Cowen and Company’s 40th Annual Health Care Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today announced that John Tucker, president and chief executive officer, will present at the Cowen and Company’s 40th Annual Health Care Conference at 8:40 a.m. ET on Wednesday, March 4, 2020, at the Boston Marriott Copley Place in Boston, MA.
Feb 20, 2020 08:00 am ET
scPharmaceuticals Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today announced that John Tucker, president and chief executive officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference at 10:00 a.m. ET on Tuesday, February 25, 2020, at the Lotte New York Palace Hotel in New York, NY.
Dec 12, 2019 08:00 am ET
scPharmaceuticals Inc. Announces Recent Progress on FUROSCIX® and Highlights Corporate Objectives
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced a progress update on FUROSCIX® including progress on both the drug and device validation, and the successful completion of the human factors program. FUROSCIX is the Company’s lead program for the treatment of congestion in patients with heart failure and the Company remains on track to resubmit the FUROSCIX New Drug Application (NDA)
Nov 26, 2019 08:00 am ET
scPharmaceuticals Inc. to Present at the Piper Jaffray 31st Annual Healthcare Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, chief executive officer, will present and host investor meetings at the Piper Jaffray 31st Annual Healthcare Conference being held at the Lotte New York Palace in New York, NY. The Company is scheduled to present on Thursday, December 5, 2019, at 8:50 a.m. ET.
Nov 14, 2019 08:00 am ET
scPharmaceuticals Inc. to Present at the Jefferies 2019 London Healthcare Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Nov 12, 2019 08:00 am ET
scPharmaceuticals Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Sep 18, 2019 08:00 am ET
scPharmaceuticals Inc. Provides FUROSCIX® Update and Announces Completion of $20.0 Million Term Loan Agreement
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Aug 07, 2019 08:00 am ET
scPharmaceuticals Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Aug 06, 2019 08:00 am ET
scPharmaceuticals Inc. to Present at the 2019 Wedbush PacGrow Healthcare Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Jul 16, 2019 08:00 am ET
scPharmaceuticals Inc. Provides Regulatory Update on FUROSCIX®
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
May 30, 2019 08:00 am ET
scPharmaceuticals Inc. to Present at Upcoming Investor Conferences
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
May 08, 2019 08:00 am ET
scPharmaceuticals Inc. Reports First Quarter 2019 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
Mar 21, 2019 08:00 am ET
scPharmaceuticals Inc. Reports Fourth Quarter and Year Ended 2018 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today...
Feb 21, 2019 08:00 am ET
scPharmaceuticals Inc. to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today...
Jan 29, 2019 08:00 am ET
scPharmaceuticals Inc. Announces Development Agreement with West Pharmaceutical Services for Next-Generation FUROSCIX® On-Body Infusor
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today...
Nov 21, 2018 08:40 am ET
Analysis: Positioning to Benefit within Stitch Fix, Veritone, TCG BDC, scPharmaceuticals, Ascent Capital Group, and Tremont Mortgage Trust — Research Highlights Growth, Revenue, and Consolidated Resul
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Stitch Fix, Inc. (NASDAQ:SFIX), Veritone, Inc. (NASDAQ:VERI), TCG BDC,...
Nov 13, 2018 08:00 am ET
scPharmaceuticals Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today...
Oct 18, 2018 07:30 am ET
scPharmaceuticals Inc. Provides Regulatory Update on FUROSCIX®
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today...
Aug 14, 2018 08:00 am ET
scPharmaceuticals Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today...
Jul 24, 2018 08:00 am ET
scPharmaceuticals Announces Appointment of Two New Directors
scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, announced the...
Jun 28, 2018 08:00 am ET
scPharmaceuticals Appoints Frederick Hudson to Board of Directors
scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, announced at...
Jun 13, 2018 08:00 am ET
scPharmaceuticals Receives Complete Response Letter from the FDA for FUROSCIX®
scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today...
May 31, 2018 08:30 am ET
scPharmaceuticals Inc. Provides Regulatory Update on FUROSCIX®
scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today...
May 30, 2018 08:00 am ET
scPharmaceuticals Inc. to Present at the Jefferies 2018 Global Healthcare Conference
scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today...
May 07, 2018 04:01 pm ET
scPharmaceuticals Inc. Reports First Quarter 2018 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today...
Mar 20, 2018 07:22 pm ET
scPharmaceuticals Inc. Reports Fourth Quarter 2017 Financial Results
Announced $147.7 Million of equity capital raising in 2017; Completed an Initial Public Offering; Advances towards FUROSCIX™ PDUFA date
Mar 01, 2018 08:00 am ET
scPharmaceuticals Inc. to Present at the Cowen 38th Annual Health Care Conference
BURLINGTON, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to transform infused therapies, advance patient care and reduce healthcare costs, today announced that...
Feb 06, 2018 08:00 am ET
scPharmaceuticals Inc. to Present at the 7th Annual Leerink Partners Global Healthcare Conference
BURLINGTON, Mass., Feb. 06, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to transform infused therapies, advance patient care and reduce healthcare costs, today announced that...
Dec 20, 2017 11:06 am ET
Dec 12, 2017 08:00 am ET
scPharmaceuticals Inc. to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
BURLINGTON, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to transform infused therapies, advance patient care and reduce healthcare costs, today announced that...
Nov 29, 2017 09:23 am ET
scPharmaceuticals Inc. Announces Closing of Over-Allotment Option in its Initial Public Offering
BURLINGTON, Mass., Nov. 29, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (the “Company” or “scPharmaceuticals”) (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to transform the way therapy is delivered, advance patient care...
Nov 29, 2017 08:00 am ET
scPharmaceuticals Inc. Announces Closing of Initial Public Offering
BURLINGTON, Mass., Nov. 29, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (the “Company”) a pharmaceutical company focused on developing and commercializing products that have the potential to transform the way therapy is delivered, advance patient care and reduce healthcare...
Nov 16, 2017 09:05 pm ET
scPharmaceuticals Inc. Announces Pricing of Initial Public Offering
BURLINGTON, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (the “Company”) a pharmaceutical company focused on developing and commercializing products that have the potential to transform the way therapy is delivered, advance patient care and reduce healthcare...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.